The Laboratory of Hemodynamics and Cardiovascular Technology is committed in advancing Medical Technology and Transferring the results to the private sector. Startups issued from LHTC activities are:
- EndoArt SA. World leader in telemetrically-controled implantable devices for the treatment of Congential Heart Disease and Morbid Obesity. Acquired by Allergan Inc. in February 2007.
- Antlia SA (www.ithetis.com). Developer of implantable drug delivery devices for preclinical research and vet care.
- Rheon Medical SA (www.rheonmedical.com). Developer of an implantable drainage device for the treatment of glaucoma
- Comphya Sàrl (www.comphya.com). Developer of implantable neuromodulator device for the treatment of erectile dyfunction